Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $60,387 - $68,493
919 Added 40.9%
3,166 $219,000
Q4 2022

Jan 11, 2023

BUY
$68.48 - $81.09 $153,874 - $182,209
2,247 New
2,247 $0
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $187,432 - $206,428
2,581 Added 18.33%
16,659 $1.28 Million
Q1 2022

Apr 20, 2022

SELL
$61.48 - $73.72 $31,354 - $37,597
-510 Reduced 3.5%
14,078 $1.03 Million
Q4 2021

Jan 12, 2022

BUY
$53.63 - $62.52 $101,146 - $117,912
1,886 Added 14.85%
14,588 $910,000
Q3 2021

Oct 12, 2021

BUY
$59.17 - $69.31 $751,577 - $880,375
12,702 New
12,702 $752,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mc Elhenny Sheffield Capital Management, LLC Portfolio

Follow Mc Elhenny Sheffield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Elhenny Sheffield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Elhenny Sheffield Capital Management, LLC with notifications on news.